داروسازی تهران شیمی

شتهران | Stocks - Iran Fara Bourse (IFB)
داروهای شیمیایی و گیاهی
Sector:

داروهای شیمیایی و گیاهی

Market Type:

Stocks

Status:

Closed

Last Price: 1,000 0.00
Close Price: 6,830

Financial Ratios

2026/05/02
Fiscal Year 2025/12/2112 Month
2025/10/04
Fiscal Year 2024/12/2012 Month
2024/10/02
Fiscal Year 2023/12/2112 Month

Net Profit to Sales

20.76.8132.49

Gross Profit to Sales

23.877.3333.21

Operating Margin

29.3518.9933.03

Gross Profit to Sales

34.1924.936.25

Net Profit to Gross Profit

60.5527.3789.64

Return on Assets (ROA)

9.232.8417.95

Return on Capital (%)

126.2428.76141.62

Return on Equity (ROE)

35.2811.6657.15

Working Capital Return

38.411.5654.75

Fixed Asset Return

74.4733.1204.73

Loan Benefit Assessment

3.824.113.18

Current Ratio

1.431.421.68

Quick Ratio

0.940.991.32

Liquidity Ratio

0.080.090.17

Net Working Capital

22,044,48016,681,15617,344,334

Current Assets Ratio

0.80.830.81

Inventory Turnover

285.72226.07152.8

Receivables Collection Period

298.11280.43235.43

Inventory to Working Capital

1.141.020.54

Working Capital Turnover

1.851.71.68

Fixed Asset Turnover

3.64.866.3

Total Asset Turnover

0.450.420.55

Debt Ratio

0.740.760.69

Debt to Equity

2.823.112.18

Long-Term Debt to Equity

0.70.70.66

Current Debt to Equity

2.132.411.52

Equity Ratio

26.1524.3231.4

Debt Coverage Ratio

0.680.50.42